Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes

Journal of Pharmaceutical Sciences

Volumn 102, Issue 11, 2013, Pages 4173-4180

  Logan, Randall ^a   Kong, Alex ^a   Krise, Jeffrey P ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Cell biology; Cell culture; Doseresponse; Drug interactions; in vitro models; Pharamcokinetics; Physicochemical properties

Indexed keywords

3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE; AMINE; AMIODARONE; BUPIVACAINE; CARBAMAZEPINE; CHLOROQUINE; HALOFANTRINE; HALOPERIDOL; IMIPRAMINE; LIDOCAINE; MEPACRINE; NAPROXEN; PROPRANOLOL; RAPAMYCIN; VALPROIC ACID;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG PENETRATION; DRUG UPTAKE; ENDOCYTOSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; LYSOSOME; PH; PHAGOCYTOSIS; PHYSICAL CHEMISTRY;

CELL BIOLOGY; CELL CULTURE; DOSERESPONSE; DRUG INTERACTIONS; IN VITRO MODELS; PHARAMCOKINETICS; PHYSICOCHEMICAL PROPERTIES;

AMINES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOPHAGY; CELL LINE; DRUG INTERACTIONS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LYSOSOMES; NAPROXEN;

EID: 84885856731     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23706     Document Type: Article

References (36)

1. de Duve C, de Barsy T, Poole B, Trouet A, Tulkens P, Van Hoof F. 1974. Commentary. Lysosomotropic agents. Biochem Pharmacol 23(18):2495-2531.
2. Marceau F, Bawolak MT, Lodge R, Bouthillier J, Gagne-Henley A, Gaudreault RC, Morissette G. 2012. Cation trapping by cellular acidic compartments: Beyond the concept of lysosomotropic drugs. Toxicol Appl Pharmacol 259(1):1-12.
3. Nadanaciva S, Lu S, Gebhard DF, Jessen BA, Pennie WD, Will Y. 2011. A high content screening assay for identifying lysosomotropic compounds. Toxicol In Vitro 25(3):715-723.
4. Lemieux B, Percival MD, Falgueyret JP. 2004. Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99. Anal Biochem 327(2):247-251.
5. Moriyama Y. 1996. Membrane energization by proton pumps is important for compartmentalization of drugs and toxins: A new type of active transport. J Exp Biol 199(Pt 7):1447-1454.
6. Duvvuri M, Gong Y, Chatterji D, Krise JP. 2004. Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60. J Biol Chem 279(31):32367-32372.
7. Duvvuri M, Konkar S, Funk RS, Krise JM, Krise JP. 2005. A chemical strategy to manipulate the intracellular localization of drugs in resistant cancer cells. Biochemistry 44(48):15743-15749.
8. Duvvuri M, Krise JP. 2005. A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict. Mol Pharm 2(6):440-448.
9. Duvvuri M, Konkar S, Hong KH, Blagg BS, Krise JP. 2006. A new approach for enhancing differential selectivity of drugs to cancer cells. ACS Chem Biol 1(5):309-315.
10. Ndolo RA, Forrest ML, Krise JP. 2010. The role of lysosomes in limiting drug toxicity in mice. J Pharmacol Exp Ther 333(1):120-128.
11. Larsen AK, Escargueil AE, Skladanowski A. 2000. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 85(3):217-229.
12. Hurwitz SJ, Terashima M, Mizunuma N, Slapak CA. 1997. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: Participation of lysosomes. Blood 89(10):3745-3754.
13. Gong Y, Duvvuri M, Krise JP. 2003. Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60. J Biol Chem 278(50):50234-50239.
14. Reasor MJ, Hastings KL, Ulrich RG. 2006. Drug-induced phospholipidosis: Issues and future directions. Expert Opin Drug Saf 5(4):567-583.
15. Funk RS, Krise JP. 2012. Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: Implications for an intracellular distribution-based drug interaction. Mol Pharm 9(5):1384-1395.
16. Kornfeld S, Mellman I. 1989. The biogenesis of lysosomes. Annu Rev Cell Biol 5:483-525.
17. Luzio JP, Poupon V, Lindsay MR, Mullock BM, Piper RC, Pryor PR. 2003. Membrane dynamics and the biogenesis of lysosomes. Mol Membr Biol 20(2):141-154.
18. Reddy A, Caler EV, Andrews NW. 2001. Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes. Cell 106(2):157-169.
19. Bright NA, Reaves BJ, Mullock BM, Luzio JP. 1997. Dense core lysosomes can fuse with late endosomes and are re-formed from the resultant hybrid organelles. J Cell Sci 110 (Pt 17):2027-2040.
20. Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC. 2005. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170(7):1101-1111.
21. Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, Jahreiss L, Fleming A, Pask D, Goldsmith P, O'Kane CJ, Floto RA, Rubinsztein DC. 2008. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol 4(5):295-305.
22. Drake KR, Kang M, Kenworthy AK. 2010. Nucleocytoplasmic distribution and dynamics of the autophagosome marker EGFP-LC3. PLoS One 5(3):e9806.
23. Williams RS, Cheng L, Mudge AW, Harwood AJ. 2002. A ommon mechanism of action for three mood-stabilizing drugs. Nature 417(6886):292-295.
24. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. 2007. Potential therapeutic applications of autophagy. Nat Rev Drug Discov 6(4):304-312.
25. Chen J, Korostyshevsky D, Lee S, Perlstein EO. 2012. Accumulation of an antidepressant in vesiculogenic membranes of yeast cells triggers autophagy. PLoS One 7(4):e34024.
26. Morissette G, Ammoury A, Rusu D, Marguery MC, Lodge R, Poubelle PE, Marceau F. 2009. Intracellular sequestration of amiodarone: Role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology. Br J Pharmacol 157(8):1531-1540.
27. Balgi AD, Fonseca BD, Donohue E, Tsang TC, Lajoie P, Proud CG, Nabi IR, Roberge M. 2009. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One 4(9):e7124.
28. Underwood KW, Andemariam B, McWilliams GL, Liscum L. 1996. Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. J Lipid Res 37(7):1556-1568.
29. Kaufmann AM, Krise JP. 2008. Niemann-Pick C1 functions in regulating lysosomal amine content. J Biol Chem 283(36):24584-24593.
30. Mizushima N, Yoshimori T, Levine B. 2010. Methods in mammalian autophagy research. Cell 140(3):313-326.
31. Tanida I, Ueno T, Kominami E. 2004. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 36(12):2503-2518.
32. Kimura S, Noda T, Yoshimori T. 2007. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3(5):452-460.
33. Zheng N, Zhang X, Rosania GR. 2011. Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine. J Pharmacol Exp Ther 336(3):661-671.
34. Katayama H, Kogure T, Mizushima N, Yoshimori T, Miyawaki A. 2011. A sensitive and quantitative technique for detecting autophagic events based on lysosomal delivery. Chem Biol 18(8):1042-1052.
35. Ishibashi S, Yamazaki T, Okamoto K. 2009. Association of autophagy with cholesterol-accumulated compartments in Niemann-Pick disease type C cells. J Clin Neurosci 16(7):954-959.
36. Chow MS. 1996. Intravenous amiodarone: Pharmacology, pharmacokinetics, and clinical use. Ann Pharmacother 30(6):637-643.